IP Library › Assignment 067678/0618
Patent Assignment
Reel/Frame 067678/0618

Assignment of Assignor's Interest

Recorded: 2024-06-10 Pages: 12
Assignor
Assignee
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
COLLEGE BUSINESS AND TECHNOLOGY PARK, CRUISERATH ROAD, BLANCHARDSTOWN, D15 TX2V, IRELAND
Covered Properties (16)
Use of Inhaled Nitric Oxide for the Improvement of Right and/or Left Ventricular Function
Use of Inhaled Nitric Oxide for the Treatment of Pulmonary Hypertension Associated with Lung Disease
Use of Inhaled Nitric Oxide and Oxygen for the Treatment of Pulmonary Hypertension
Pulsed Administration of Inhaled Nitric Oxide for the Treatment of Pulmonary Hypertension
Use of Inhaled Nitric Oxide (Ino) for Treating Patients with Pulmonary Hypertension Associated with Sarcoidosis (Ph-Sarc)
Use Of Inhaled Nitric Oxide And Oxygen For The Treatment Of Pulmonary Hypertension
Application: 16/961,886 →
Publication: US 2020/0360425
Method and Apparatus for Pulsatile Delivery of Nitric Oxide
Application: 17/055,365 →
Publication: US 2021/0220586
USE OF INHALED NITRIC OXIDE (iNO) FOR IMPROVING ACTIVITY LEVELS IN PATIENTS WITH LUNG-RELATED CONDITIONS
Application: 17/420,406 →
Publication: US 2022/0080147
Combination Drug Therapies of Pde-5 Inhibitors and Inhaled Nitric Oxide
Application: 17/421,803 →
Publication: US 2022/0096535
IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENT
Application: 17/796,451 →
Publication: US 2023/0067942
USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19
Application: 17/917,209 →
Publication: US 2023/0158064
Method for Pulsatile Delivery of a Gaseous Drug
Application: 18/000,188 →
Publication: US 2023/0201497
Use Of Inhaled Nitric Oxide For The Improvement Of Right And/Or Left Ventricular Function
Application: 62/552,022 →
Use Of Inhaled Nitric Oxide And Oxygen For The Treatment Of Pulmonary Hypertension
Application: 62/611,316 →
Use Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension Associated With Lung Disease
Application: 62/611,325 →
Pulsed Administration Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension
Application: 62/611,331 →
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 24, 2024
From: SHAH, PARAG
To: BELLEROPHON THERAPEUTICS, INC.
Reel/Frame 069675/0930 →
Assignment of Assignor's Interest Dec 24, 2024
From: DEKKER, MARTIN
To: BELLEROPHON THERAPEUTICS, INC.
Reel/Frame 069676/0011 →
Security Interest Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →
Security Interest Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →
Assignment of Assignor's Interest Feb 26, 2026
From: QUINN, DEBORAH; SHAH, PARAG
To: BELLEROPHON PULSE TECNOLOGIES LLC
Reel/Frame 073910/0465 →
Assignment of Assignor's Interest Mar 4, 2026
From: SHAH, PARAG; FERNANDES, PETER
To: BELLEROPHON THERAPEUTICS
Reel/Frame 073967/0353 →